Zenas BioPharma Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022
Period Ending	Oct '25 Oct 6, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Market Capitalization	970	342	-	-
Enterprise Value	722	-44	-	-
Last Close Price	21.76	8.19	-	-
PS Ratio	48.36	68.45	-	-
PB Ratio	3.82	1.10	-	-
P/TBV Ratio	4.15	1.10	-	-
Debt / Equity Ratio	0.00	0.00	0.87	0.03
Asset Turnover	0.06	0.02	0.70	-
Quick Ratio	5.16	6.12	2.44	2.59
Current Ratio	5.23	6.21	2.57	2.64
Return on Equity (ROE)	-88.40%	-93.22%	-102.89%	-
Return on Assets (ROA)	-47.94%	-46.76%	-23.77%	-
Return on Capital (ROIC)	-58.80%	-57.07%	-35.79%	-
Earnings Yield	-17.80%	-45.87%	-	-
FCF Yield	-14.93%	-35.00%	-	-
Buyback Yield / Dilution	-2050.40%	-762.01%	-2.61%	-

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q